Addresses
Introduction
Current methods for the detection and monitoring of patients with B-cell dyscrasias are only of use when plasma cell populations produce a large or detectable monoclonal component (M-protein). They have limited use in identifying patients with light chain multiple myeloma, non-secretory multiple myeloma and AL amyloidosis in which an M-protein may not be detectable. In order to identify and monitor these patients an alternative assay has been developed to identify, characterize and quantitate serum free light chains. The only commercially quantitative assay currently available for free light chains became available in 2001 (FREELITEt,The Binding Site Ltd, Birmingham, UK). 1 This assay measures k and l light chains that are not bound to immunoglobulin heavy chain and it can now be performed on a number of automated laboratory platforms. However, there is no international standard available for free light chain (FLC) analysis. Furthermore, a single reagent source does not guarantee consistent FLC values between assay systems and reagent lots. This may have implications for patients being monitored using FLC measurements over prolonged periods of time. 2 The purpose of the present study was to determine whether the FREELITEt assay produced comparable results on two di¡erent analytical platforms, the Dade Behring BNII nephelometer (Dade Behring Limited, Milton Keynes, UK) and the Olympus AU 400 analyser (Olympus Optical Co. (UK) Ltd, Middlesex, UK).
Methods

Patient samples
The samples used in the study were routine samples collected from 112 patients and submitted to the Department for serum electrophoresis for the investigation of B-cell dyscrasias. They were collected by venepuncture into Becton Dickinson serum separator (SST II) Advance Vacutainert tubes. Samples were allowed to clot and the serum was separated by centrifugation at 101C for 7 min at 3000 rpm. Samples were stored at 41C prior to analysis, or at À801C for prolonged storage. Ethical approval was applied for and approval for the project given.
Method comparison
Samples were analysed on each analyser (Dade Behring BNII nephelometer and the Olympus AU 400) in a single batch. In order to ensure no analytical drift occurred, internal quality control material was analysed at the beginning and end of the run.
Determination of reference intervals
Serum FLC reference intervals on the BNII and AU400 were established using samples from 126 ostensibly normal anonymous individuals, according to The International Federation of Clinical Chemistry (IFCC) and National Committee for Clinical Laboratory Standards (NCCLS) guidelines. 3, 4 In selecting these individuals, patients with B cell dyscrasias as detected by serum protein electrophoresis and immuno¢xation were excluded. In addition, individuals with other disorders known to cause elevations in serum FLC values such as renal failure were also excluded from analysis.
Statistical analysis
Data obtained from the method comparison was analysed using least squares regression and Bland-Altman bias plots. 5 Ninety ¢ve percent reference intervals were obtained using non parametric statistics. All statistical analysis was performed using Analyse-it for Microsoft Excel, Leeds, UK. See http://www.analyse-it.com
Results
Method comparison
Results of the method comparison on the BNII and greatest di¡erence being observed in the measurement of free l light chain values. This means the calculated k/l FLC ratio on the BNII is lower than that on the AU400 (Figure 1c ). Due to the apparent di¡erence between measured k and l serum FLC values on the BNII and AU400 analysers, reference intervals for the assays were subsequently established on each platform.
Serum free light chain reference interval
Reference interval data for the k/l FLC ratio on the AU400 and BNII are shown in Figures 2a and b as frequency distribution and box and whisker plots. A summary of the reference intervals established for serum FLCs in this study is shown in Table 1 ; also shown are the 95% reference intervals published by The Binding Site.
Discussion
The reference data obtained re£ects the ¢ndings of the comparison study. Higher measured values for k and l FLCs were obtained on the BNII, compared to the AU400, with the greatest di¡erence being observed in the measurement of the free l light chain. This in turn led to a lower k/l ratio being obtained on the BNII than on the AU400. Consequently the reference interval established for the BNII re£ected this, having lower upper and lower reference limits than that determined for the AU400. As far as we are aware,The Binding Site has quoted identical reference intervals for all established analytical platforms. 6 However, the ¢ndings of the present study clearly indicate the need for analyser-speci¢c ones. Support for this strategy comes from a recent publication outlining an evaluation of the assay on the Beckman Coulter Immage. 7 Here the authors determined reference intervals for this analyser and concluded that all laboratories performing the assay should establish their own reference intervals. The Binding Site have been consulted regarding these di¡erences and stated that since the BNII is an endpoint nephelometer and the AU400 an endpoint turbidimeter, platform di¡erences are expected. They also emphasized the importance of optimal reagent storage where data is collected over a number of analytical runs. Important considerations regarding assay performance have also been highlighted in an independent review. 2 In it, the authors raised several issues including non linearity of assay response, di¡erences in the immunoreactivity of monoclonal components compared with the calibrator and lack of daily cuvette washing (on analysers with reusable cuvettes) as possible causes of inaccurate or imprecise results. In this study we determined a 95% reference interval for the k/l ratio. However, it is of note that The Binding Site quotes a diagnostic range rather than a reference interval for the k/l ratio of 0.26--1.65. This is a 100% range and is adopted to avoid the 5% false positive rate which arises when 95% reference intervals are applied. However, its use is not recommended by either the IFCC or the NCCLS guidelines for reference interval establishment. 3, 4 For this reason the diagnostic range was not adopted in this study.
In conclusion, this small study has shown that measurement of serum free light chains on di¡erent analytical platforms can give di¡erent results betweenplatform. It has also highlighted that because of these di¡erences, analyser-speci¢c reference intervals should always be determined when establishing these assays. These ¢ndings have highlighted the need for further work in this area to see if they can be con¢rmed both on a larger cohort of individuals using not only the BNII and AU400, but also other analytical platforms.
